Seglin Technology: A Major Source of Novel Small-Molecule Drugs
Second generation leads from iminosugars (SeglinsTM) show improved
potency and selectivity over earlier examples and offer potential as novel
small-molecule drugs across a wide range of therapeutic areas.
Richard Storer and Graeme Horne at Summit plc (September 2010)
Keywords: Second generation iminosugars SeglinsTM
potency selectivity novel
small-molecule drugs therapeutic